Gut microbiome and pediatric multiple sclerosis

Abstract

Half of our cells and only 1 in 100 of our genes are human; the rest comprise microbes, termed the human microbiota. Over 90% of these microbes live in the large intestine. Aside from aiding food digestion, these diverse microbes can also synthesize essential vitamins or amino acids, educate and modulate the immune system response, and influence susceptibility or resistance to infections. Their potential to influence neurological conditions such as multiple sclerosis (MS) is intriguing. The overarching goal of this Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) presentation was to provide a high-level insight into gut microbiota’s potential role in pediatric MS. Two specific questions were also addressed based on published work: (1) Does the gut microbiota differ between children with and without MS? and (2) Is the gut microbiota associated with future relapse risk?

Keywords

Microbiome microbiota disease-modifying therapies case–control pediatric multiple sclerosis relapse risk

Get full access to this article

View all access options for this article.

References

Berer

Krishnamoorthy

Microbial view of central nervous system autoimmunity. FEBS Lett 2014; 588: 4207–4213.

Wang

Kasper

LH.

The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38: 1–12.

Lee

Menezes

Umesaki

et al . Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011; 108: 4615–4622.

Berer

Mues

Koutrolos

et al . Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479: 538–541.

Tremlett

Bauer

Appel Cresswell

et al . The gut microbiome in human neurological disease: A review. Ann Neurol 2017; 81: 369–382.

Sampson

Mazmanian

SK.

Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 2015; 17: 565–576.

Bauer

Huus

Finlay

BB.

Microbes and the mind: Emerging hallmarks of the gut microbiota-brain axis. Cell Microbiol 2016; 18: 632–644.

Dinan

Cryan

JF.

Gut instincts: Microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol 2017; 15: 489–503.

Tremlett

Fadrosh

Faruqi

et al . Gut microbiota in early pediatric multiple sclerosis: A case-control study. Eur J Neurol 2016; 23: 1308–1321.

10.

Nagalingam

Lynch

SV.

Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2012; 18: 968–984.

11.

Tremlett

Waubant

The multiple sclerosis microbiome

? Ann Transl Med 2017; 5: 53.

12.

Tremlett

Fadrosh

Faruqi

et al . Gut microbiota composition and relapse risk in pediatric MS: A pilot study. J Neurol Sci 2016; 363: 153–157.

13.

Telesford

Yan

Ochoa-Reparaz

et al . A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39+ Foxp3+ T cells and T_reg function. Gut Microbes 2015; 6: 234–242.

14.

Tremlett

Fadrosh

Faruqi

et al . Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls. BMC Neurol 2016; 16: 182.

15.

Jangi

Gandhi

Cox

et al . Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 2016; 7: 12015.

16.

Miyake

Kim

Suda

et al . Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PloS ONE 2015; 10: e0137429.

17.

Cantarel

Waubant

Chehoud

et al . Gut microbiota in multiple sclerosis: Possible influence of immunomodulators. J Investig Med 2015; 63: 729–734.

18.

Chen

Chia

Kalari

et al . Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 2016; 6: 28484.

19.

Langille

Zaneveld

Caporaso

et al . Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013; 31: 814–821.